Eli Lilly surpassed a $1 trillion market capitalization this week. Why? Expectations-beating growth from Mounjaro and ...

It’s the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

From Ian Somerhalder to Bridget Fonda, these famous faces said goodbye to the silver screen despite their stardom – here are ...

President Donald Trump unveiled a major pricing and coverage deal with drug giants Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) on Thursday, pledging to make blockbuster weight-loss ...

Eli Lilly is dominating the large and rapidly growing incretin analog market in the U.S. with its GLP-1 drug, tirzepatide. Its investigational oral GLP-1 drug, orforglipron, could significantly expand ...

Want to see more of NewsNation? Get 24/7 fact-based news coverage with the NewsNation app or add NewsNation as a preferred source on Google! Eli Lilly is also negotiating for a government voucher that ...

Those millions of dead people supposedly claiming Social Security? It’s obvious now that they were bogus. Bodies keep turning up near luxury ocean homes — what to know about the eerie cliffside deaths ...

Earnings calls, loved by some CFOs and dreaded by others, allow finance leaders and their fellow executives to verbalize their organization’s progress. Each month, CFO.com compiles interesting ...

Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, Endpoints News ...